Modern medicine has evolved so much so that sooner or later every breastfeeding mother needs to take it in one form or other. Medication that is present in mothers blood will transfer into her breast milk to some extent. Most drugs do so at low levels and pose no real risk to infants but then there are some exceptions. In This post will discuss whether Carbamazepine Tablet is safe in breast-feeding or not.
What is Carbamazepine Tablet used for?
Epilepsy Carbamazepine tablets, USP are indicated for use as an anticonvulsant drug. Evidence supporting efficacy of carbamazepine as an anticonvulsant was derived from active drug-controlled studies that enrolled patients with the following seizure types: Partial seizures with complex symptomatology (psychomotor, temporal lobe). Patients with these seizures appear to show greater improvement than those with other types. Generalized tonic-clonic seizures (grand mal). Mixed seizure patterns which include the above, or other partial or generalized seizures. Absence seizures (petit mal) do not appear to be controlled by carbamazepine (see PRECAUTIONS , General ). Trigeminal Neuralgia Carbamazepine tablets, USP are indicated in the treatment of the pain associated with true trigeminal neuralgia. Beneficial results have also been reported in glossopharyngeal neuralgia. This drug is not a simple analgesic and should not be used for the relief of trivial aches or pains.
Is Carbamazepine Tablet usage safe while breastfeeding? If a lactating mother is using it can there be any effect on growth or development of infant?
As per our analysis Carbamazepine Tablet contains only one ingredient and that is Carbamazepine. We have analyzed Carbamazepine and it seems to be safe to use Carbamazepine while breastfeeding, that means usage of Carbamazepine Tablet shall be safe while breastfeeding. Below you can check more details of Carbamazepine usage in breastfeeding. We recommend you to go through provided detailed analysis as below take decision accordingly.
Statement of Manufacturer/Labeler about breastfeeding usage
Nursing Mothers Carbamazepine and its epoxide metabolite are transferred to breast milk. The ratio of the concentration in breast milk to that in maternal plasma is about 0.4 for carbamazepine and about 0.5 for the epoxide. The estimated doses given to the newborn during breastfeeding are in the range of 2 to 5 mg daily for carbamazepine and 1 to 2 mg daily for the epoxide. Because of the potential for serious adverse reactions in nursing infants from carbamazepine, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.
Carbamazepine Tablet Breastfeeding Analsys
Carbamazepine while Breastfeeding Safe
CAS Number: 298-46-4
Excreted into breast milk in moderate amount that could arrive to be significant. Most infants reported were not found of suffering clinical issues at short or long term. However, serum levels have reached a low range of therapeutic levels, with isolated cases of somnolence, poor feeding and transient liver dysfunction with associated cholestasis. One case of Deprivation Syndrome has been reported after sudden discontinuation of medication. The American Academy of Pediatrics rates it as usually compatible with Breastfeeding. Eleventh WHO Model List of Essential Drugs 2002: Compatible with breastfeeding.
Carbamazepine Tablet Breastfeeding Analsys - 2
Carbamazepine while Breastfeeding
CAS Number: 298-46-4
Breastfeeding during carbamazepine monotherapy does not appear to adversely affect infant growth or development, and breastfed infants had higher IQs and enhanced verbal abilities than nonbreastfed infants at 6 years of age in one study. If carbamazepine is required by the mother, it is not necessarily a reason to discontinue breastfeeding. Carbamazepine has relatively high levels in breastmilk and breastfed infants have serum levels that are measurable, but usually below the anticonvulsant therapeutic range. Most infants have had no adverse reactions, but sedation, poor sucking, withdrawal reactions and 3 cases of hepatic dysfunction have been reported. These have all been complicated because of intrauterine exposure and, in some cases, concurrent drug therapy. Monitor the infant for jaundice, drowsiness, adequate weight gain, and developmental milestones, especially in younger, exclusively breastfed infants and when using combinations of anticonvulsant or psychotropic drugs. One author recommends monitoring infant serum carbamazepine levels, liver enzymes, and a complete blood count during therapy.
I am nursing mother and I have already used Carbamazepine Tablet, what should I do?
Carbamazepine Tablet is safe in breastfeeding and should not create any health problem for your baby but in case you feel any health issue associated with Carbamazepine Tablet you should contact your doctor or health care provider. Be it pregnancy or lactation you shall keep your doctor informed.
I am nursing mother and my doctor has suggested me to use Carbamazepine Tablet, is it safe?
Definitely, Carbamazepine Tablet is safe in lactation for baby. No wonder your doctor has recommended it.
If I am using Carbamazepine Tablet, will my baby need extra monitoring?
No extra baby monitoring required while mother is using Carbamazepine Tablet
Who can I talk to if I have questions about usage of Carbamazepine Tablet in breastfeeding?
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week